These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17335959)

  • 1. Editorial comment on: extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial.
    Lazzeri M
    Eur Urol; 2007 Sep; 52(3):882. PubMed ID: 17335959
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial.
    Fowler CJ
    Eur Urol; 2007 Sep; 52(3):882-3. PubMed ID: 17335963
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial.
    Morris AR; O'Sullivan R; Dunkley P; Moore KH
    Eur Urol; 2007 Sep; 52(3):876-81. PubMed ID: 17335962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children.
    Bael A; Lax H; de Jong TP; Hoebeke P; Nijman RJ; Sixt R; Verhulst J; Hirche H; van Gool JD;
    J Urol; 2008 Oct; 180(4):1486-93; discussion 1494-5. PubMed ID: 18710726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal magnetic innervation therapy: assessment of clinical efficacy in relation to urodynamic parameters.
    Groenendijk PM; Halilovic M; Chandi DD; Heesakkers JP; Voorham-Van Der Zalm PJ; Lycklama Anijeholt AA
    Scand J Urol Nephrol; 2008; 42(5):433-6. PubMed ID: 18609269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
    Sahai A; Khan MS; Dasgupta P
    J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of preoperative pressure-flow studies in the resolution of detrusor overactivity and overactive bladder after tension-free vaginal tape insertion.
    Duckett JR; Basu M
    BJU Int; 2007 Jun; 99(6):1439-42. PubMed ID: 17419703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between micturition urgency and involuntary voiding dynamics in men with urinary incontinence from idiopathic detrusor overactivity.
    Cucchi A; Quaglini S; Rovereto B
    J Urol; 2007 Aug; 178(2):563-7; discussion 567. PubMed ID: 17570436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment on: neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
    Wyndaele JJ
    Eur Urol; 2008 May; 53(5):1019-20. PubMed ID: 17950988
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Kabay et al.: Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. (Urology 2008;71:641-645).
    Rijkhoff NJ
    Urology; 2008 Nov; 72(5):1186; author reply 1186-7. PubMed ID: 18984145
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Fowler CJ
    Eur Urol; 2009 Mar; 55(3):712. PubMed ID: 18814958
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Schurch B
    Eur Urol; 2009 Mar; 55(3):711-2. PubMed ID: 18814956
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient controlled versus automatic stimulation of pudendal nerve afferents to treat neurogenic detrusor overactivity.
    Opisso E; Borau A; Rodríguez A; Hansen J; Rijkhoff NJ
    J Urol; 2008 Oct; 180(4):1403-8. PubMed ID: 18710774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urethral instability and sacral nerve stimulation-a better parameter to predict efficacy?
    Groenendijk PM; Heesakkers JP; Lycklama A Nijeholt AA
    J Urol; 2007 Aug; 178(2):568-72; discussion 572. PubMed ID: 17570438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
    Chartier-Kastler E
    BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study.
    Kabay SC; Yucel M; Kabay S
    Urology; 2008 Apr; 71(4):641-5. PubMed ID: 18387393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease.
    Kabay SC; Kabay S; Yucel M; Ozden H
    Neurourol Urodyn; 2009; 28(1):62-7. PubMed ID: 18837432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A; Mearini E; Del Zingaro M; Porena M
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going.
    Sahai A; Khan MS; Gregson N; Smith K; Dasgupta P;
    Nat Clin Pract Urol; 2007 Jul; 4(7):379-86. PubMed ID: 17615549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voiding dysfunction after radical retropubic prostatectomy: more than external urethral sphincter deficiency.
    Porena M; Mearini E; Mearini L; Vianello A; Giannantoni A
    Eur Urol; 2007 Jul; 52(1):38-45. PubMed ID: 17403565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.